<Suppliers Price>

NF 546

Names

[ CAS No. ]:
1006028-37-0

[ Name ]:
NF 546

[Synonym ]:
Tetrasodium {carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyliminobenzene-1,2,4-triylbis(methylene)]}tetrakis[hydrogen (phosphonate)]
Phosphonic acid, [carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyliminobenzene-1,2,4-triylbis(methylene)]]tetrakis-, sodium salt (1:4)

Biological Activity

[Description]:

NF546 is a selective non-nucleotide P2Y11 agonist with a pEC50 of 6.27. NF546 stimulates release of interleukin-8 from human monocyte-derived dendritic cells[1].

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> P2Y Receptor
Research Areas >> Inflammation/Immunology

[Target]

pEC50: 6.27 (P2Y11)[1]


[In Vitro]

NF546 is relatively selective for P2Y11 over P2Y1, P2Y2, P2Y4, P2Y6, P2Y12, P2X1, P2X2, and P2X2-X3. NF546 (100 μM; 24 hours) is equi-efficacious in stimulating TSP-1 release and inhibiting the LPS-induced release of IL-12p70 in human monocyte-derived dendritic cells[1].

[References]

[1]. Meis S, et al. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. J Pharmacol Exp Ther. 2010 Jan;332(1):238-47.

Chemical & Physical Properties

[ Molecular Formula ]:
C47H44N6Na4O17P4

[ Molecular Weight ]:
1180.736

[ Exact Mass ]:
1180.130371

Related Compounds